Evidence map›Paper›PMID 37624892›Full record

ArticleScience advances2023

ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy.

Michael J Bround, Julian R Havens, Allen J York, Michelle A Sargent, Jason Karch, Jeffery D Molkentin

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. The two faces of mitochondrial CaJournal of physiology and biochemistry · 2026
    Review
  4. Article
  5. Article
  6. Phenotypic CRISPR screens identify NLRX1 as an essential activator of the human mitochondrial permeability transition.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mitochondrial DNA depletion syndrome and its cardiac complication.Frontiers in cardiovascular medicine · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael J BroundDepartment of Pediatrics, Cincinnati Children's Hospital and the University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0003-3238-5489
Julian R HavensDepartment of Pediatrics, Cincinnati Children's Hospital and the University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0001-6242-0965
Allen J YorkDepartment of Pediatrics, Cincinnati Children's Hospital and the University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0002-3174-0306
Michelle A SargentDepartment of Pediatrics, Cincinnati Children's Hospital and the University of Cincinnati, Cincinnati, OH, USA.
Jason KarchDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-3023-7469
Jeffery D MolkentinDepartment of Pediatrics, Cincinnati Children's Hospital and the University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0002-3558-6529
Cincinnati Children's Hospital Medical Center · USBaylor College of Medicine · US

Funding

Molecular examination of mitochondrial calcium controlR01HL132831 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BERS, DONALD M, MOLKENTIN, JEFFERY D · 2016 to 2024
$5.9M
Molecular Regulation of Mitochondrial Permeability Transition and its Role in Regulated NecrosisR01HL150031 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Jason Michael Karch · 2020 to 2026
$2.9M
In vivo role of the fibroblast in muscular dystrophy-RenewalR01AR071301 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Jeffery D Molkentin, Davy Vanhoutte · 2018 to 2026
$2.4M
Mitochondrial regulation of calcium homeostasis and cell death in muscular dystrophyK99AR078253 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI BROUND, MICHAEL · 2021 to 2022
$181k
NHLBI NIH HHS R01 HL132831NHLBI NIH HHS R01 HL150031NIAMS NIH HHS K99 AR078253NIAMS NIH HHS R01 AR071301
6 · The paper itself

Abstract

Mitochondrial permeability transition pore (MPTP) formation contributes to ischemia-reperfusion injury in the heart and several degenerative diseases, including muscular dystrophy (MD). MD is a family of genetic disorders characterized by progressive muscle necrosis and premature death. It has been proposed that the MPTP has two molecular components, the adenine nucleotide translocase (ANT) family of proteins and an unknown component that requires the chaperone cyclophilin D (CypD) to activate. This model was examined in vivo by deleting the gene encoding ANT1 (

Indexed as

Muscular DystrophiesAnimalsCell DeathDisease Models, AnimalMiceNecrosisPeptidyl-Prolyl Isomerase FPeptidyl-Prolyl Isomerase F

Identifiers

PMID37624892
PMCPMC10456852
OpenAlexW4386156605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.